Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

May 21, 2024

Lou Lintereur, Chief Engineer for automated delivery systems at Medtronic Diabetes, brought his knowledge from working as an aerospace engineer at NASA  to developing technology for those living with diabetes.  He introduces the MiniMed 780G, a closed-loop system that combines an insulin pump and continuous glucose...


May 21, 2024

Lou Lintereur, Chief Engineer for automated delivery systems at Medtronic Diabetes, brought his knowledge from working as an aerospace engineer at NASA  to developing technology for those living with diabetes.  He introduces the MiniMed 780G, a closed-loop system that combines an insulin pump and continuous glucose...


Aug 30, 2023

Steve Kent is Chief Product Officer at Know Labs, which has developed a new sensor that uses noninvasive radiofrequency spectroscopy to measure molecules in the body.  Their first target is to non-invasively measure glucose to help those with diabetes manage their conditions more effectively. As a sensor...


Aug 30, 2023

Steve Kent is Chief Product Officer at Know Labs, which has developed a new sensor that uses noninvasive radiofrequency spectroscopy to measure molecules in the body.  Their first target is to non-invasively measure glucose to help those with diabetes manage their conditions more effectively. As a sensor...


Aug 25, 2022

Dr. Anthony Japour is the Chief Executive Officer and President at iTolerance, an early-stage privately-held regenerative medicine company. Currently, if a patient receives a pancreatic islet transplant to treat type 1 diabetes, there is a need for lifelong immune suppression. The technology that iTolerance is...